Ephedrine is used to treat low blood pressure and to relieve symptoms of asthma and congestion by opening airways and improving breathing. It can also help with nasal congestion and wheezing.[2] Ephedrine Sulfate is currently approved and in use across 25 indications[4].[1]
Ephedrine Sulfate is one of 370 small molecule programs targeting Cesarean Section. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
175 competitors in Asthma
Ephedrine Sulfate
Paracetamol
Blood Withdrawn
Blood Collection
Lexapro
Biological Drug
Guanidine Hydrochloride
Rhinovirus
FP/SAL
Biologic Therapy
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 27, 2017
CORPHEDRA
NDA NDA208943
Mar 1, 2017
EPHEDRINE SULFATE
NDA NDA208609
Jun 14, 2021
REZIPRES
NDA NDA213536
Aug 2, 2021
AKOVAZ
NDA NDA208289
Apr 22, 2022
EPHEDRINE SULFATE
NDA NDA213994
Feb 28, 2023
EMERPHED
NDA NDA213407
Sources
Details